Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
HumanPhenoHypoplasia of the bladder

WNT4 GRIP1 ROBO1

1.93e-058373HP:0005343
DomainBRK

CHD9 CHD8 CHD6

6.64e-0661313SM00592
DomainBRK_domain

CHD9 CHD8 CHD6

6.64e-0661313IPR006576
DomainBRK

CHD9 CHD8 CHD6

6.64e-0661313PF07533
DomainVWF_dom

AMN ZAN THBS1 FCGBP PXDNL

1.09e-05421315IPR001007
DomainGPS

ADGRB3 ADGRL4 ADGRG2 PKD1

9.11e-05341314SM00303
DomainGPS

ADGRB3 ADGRL4 ADGRG2 PKD1

1.02e-04351314PF01825
DomainVWFC_1

AMN ZAN THBS1 PXDNL

1.14e-04361314PS01208
DomainGPS

ADGRB3 ADGRL4 ADGRG2 PKD1

1.14e-04361314PS50221
DomainGPS

ADGRB3 ADGRL4 ADGRG2 PKD1

1.28e-04371314IPR000203
DomainVWFC_2

AMN ZAN THBS1 PXDNL

1.42e-04381314PS50184
DomainVWC

ZAN THBS1 FCGBP PXDNL

1.42e-04381314SM00214
DomainTILa_dom

ZAN FCGBP

1.46e-0431312IPR025615
DomainTILa

ZAN FCGBP

1.46e-0431312PF12714
DomainMFS_dom

SLC22A23 SLCO1B3 SLCO1B1 MFSD14B SLC15A4 SLC22A14

3.66e-041341316IPR020846
DomainUPA

UNC5B UNC5CL

4.82e-0451312PF17217
DomainUPA

UNC5B UNC5CL

4.82e-0451312IPR033772
DomainChromo_domain

CHD9 CHD8 CHD6

6.13e-04241313IPR023780
DomainChromo

CHD9 CHD8 CHD6

7.79e-04261313PF00385
DomainCHROMO_1

CHD9 CHD8 CHD6

9.72e-04281313PS00598
DomainCHROMO_2

CHD9 CHD8 CHD6

9.72e-04281313PS50013
DomainMFS

SLC22A23 SLCO1B3 SLCO1B1 MFSD14B SLC22A14

9.84e-041081315PS50850
DomainTSP_1

ADAMTS4 UNC5B ADGRB3 THBS1

1.00e-03631314PF00090
DomainTSP1

ADAMTS4 UNC5B ADGRB3 THBS1

1.12e-03651314SM00209
DomainTSP1_rpt

ADAMTS4 UNC5B ADGRB3 THBS1

1.12e-03651314IPR000884
DomainTSP1

ADAMTS4 UNC5B ADGRB3 THBS1

1.12e-03651314PS50092
Domain-

CPA3 CPB1

1.33e-03813123.30.70.340
DomainPropep_M14

CPA3 CPB1

1.33e-0381312PF02244
DomainM14A_act_pep

CPA3 CPB1

1.33e-0381312IPR003146
DomainSNF2_N

CHD9 CHD8 CHD6

1.44e-03321313IPR000330
DomainSNF2_N

CHD9 CHD8 CHD6

1.44e-03321313PF00176
DomainChromodomain-like

CHD9 CHD8 CHD6

1.44e-03321313IPR016197
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

OGT TNPO2 ADGRB3 APBB2 CHD9 FAM53C HNRNPF MIPOL1 THBS1 SEPTIN3 PKD1 ROBO1 CHD6 IFT122 SEPTIN7 WDR17 HECTD1 ARHGAP21 AGAP1

5.97e-0712851351935914814
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

OGT RPH3AL IMPA2 PPFIBP2 ZNF875 SLC22A23 APBB2 CHD9 WNT4 YJEFN3 ZP3 HNRNPF MIPOL1 SHANK2 SUPT6H PRKCE CHD6 IFT122 HECTD1 AGAP1

1.30e-0614891352028611215
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ADGRB3 CHD8 NCAPH ACSBG1 SUPT6H ANAPC2 MED12L TNKS1BP1 WDR90 GARRE1 AGAP1

7.46e-065291351114621295
Pubmed

Mechanism of lipid induced insulin resistance: activated PKCĪµ is a key regulator.

LEPR PRKCE

1.50e-052135221236337
Pubmed

Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis.

SLCO1B3 SLCO1B1

1.50e-052135229944058
Pubmed

SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome.

SLCO1B3 SLCO1B1

1.50e-052135236964102
Pubmed

Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.

SLCO1B3 SLCO1B1

1.50e-052135223340295
Pubmed

Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition.

SLCO1B3 SLCO1B1

1.50e-052135229777022
Pubmed

Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.

SLCO1B3 SLCO1B1

1.50e-052135226191226
Pubmed

Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.

SLCO1B3 SLCO1B1

1.50e-052135224194513
Pubmed

Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.

SLCO1B3 SLCO1B1

1.50e-052135224855184
Pubmed

Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.

SLCO1B3 SLCO1B1

1.50e-052135226474710
Pubmed

Effects of anthocyans on the expression of organic anion transporting polypeptides (SLCOs/OATPs) in primary human hepatocytes.

SLCO1B3 SLCO1B1

1.50e-052135225578040
Pubmed

Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.

STRC STRCP1

1.50e-052135234910522
Pubmed

Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.

SLCO1B3 SLCO1B1

1.50e-052135224989890
Pubmed

Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.

SLCO1B3 SLCO1B1

1.50e-052135221719246
Pubmed

Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.

SLCO1B3 SLCO1B1

1.50e-052135220877131
Pubmed

Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid.

ANKK1 LEPR

1.50e-052135225740917
Pubmed

Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.

SLCO1B3 SLCO1B1

1.50e-052135216534140
Pubmed

Inhibition of PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin clearance.

LEPR PRKCE

1.50e-052135217908560
Pubmed

Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.

SLCO1B3 SLCO1B1

1.50e-052135218321482
Pubmed

Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.

SLCO1B3 SLCO1B1

1.50e-052135218314419
Pubmed

OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.

SLCO1B3 SLCO1B1

1.50e-052135221691816
Pubmed

Linking organic anion transporting polypeptide 1B1 and 1B3 (OATP1B1 and OATP1B3) interaction profiles to hepatotoxicity - The hyperbilirubinemia use case.

SLCO1B3 SLCO1B1

1.50e-052135228063966
Pubmed

Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.

SLCO1B3 SLCO1B1

1.50e-052135222240838
Pubmed

Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.

SLCO1B3 SLCO1B1

1.50e-052135217412826
Pubmed

Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.

STRC STRCP1

1.50e-052135211687802
Pubmed

Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.

LEPR GUCY2C

1.50e-052135231485718
Pubmed

Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.

SLCO1B3 SLCO1B1

1.50e-052135222771883
Pubmed

Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.

SLCO1B3 SLCO1B1

1.50e-052135218180273
Pubmed

Structure of human drug transporters OATP1B1 and OATP1B3.

SLCO1B3 SLCO1B1

1.50e-052135237723174
Pubmed

Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib.

SLCO1B3 SLCO1B1

1.50e-052135223670789
Pubmed

Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.

SLCO1B3 SLCO1B1

1.50e-052135217496208
Pubmed

Rotor Syndrome

SLCO1B3 SLCO1B1

1.50e-052135223236639
Pubmed

Septin 7 mediates high glucose-induced podocyte apoptosis.

LEPR SEPTIN7

1.50e-052135230361092
Pubmed

Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver.

SLCO1B3 SLCO1B1

1.50e-052135227098745
Pubmed

Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.

SLCO1B3 SLCO1B1

1.50e-052135224740327
Pubmed

UGT-dependent regioselective glucuronidation of ursodeoxycholic acid and obeticholic acid and selective transport of the consequent acyl glucuronides by OATP1B1 and 1B3.

SLCO1B3 SLCO1B1

1.50e-052135231299240
Pubmed

In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia.

SLCO1B3 SLCO1B1

1.50e-052135223886114
Pubmed

Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.

PKD1 PAPPA

1.50e-052135231990681
Pubmed

OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture.

SLCO1B3 SLCO1B1

1.50e-052135221787759
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

TMEM94 UNC5B APBB2 RAB11FIP1 GRIP1 BSG ROBO1 ARHGAP21 AGAP1

4.18e-05421135936976175
Pubmed

Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.

SLCO1B3 SLCO1B1

4.48e-053135231047942
Pubmed

Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.

SLCO1B3 SLCO1B1

4.48e-053135226146841
Pubmed

Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.

STRC STRCP1

4.48e-053135230801007
Pubmed

SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.

SLCO1B3 SLCO1B1

4.48e-053135224762081
Pubmed

Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR.

SLCO1B3 SLCO1B1

4.48e-053135218296417
Pubmed

Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.

SLCO1B3 SLCO1B1

4.48e-053135220660695
Pubmed

Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.

SLCO1B3 SLCO1B1

4.48e-053135222136368
Pubmed

Impact of regulatory polymorphisms in organic anion transporter genes in the human liver.

SLCO1B3 SLCO1B1

4.48e-053135219620935
Pubmed

Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity.

SLCO1B3 SLCO1B1

4.48e-053135218492796
Pubmed

Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx.

SLCO1B3 SLCO1B1

4.48e-053135228389619
Pubmed

Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.

SLCO1B3 SLCO1B1

4.48e-053135223986199
Pubmed

Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy.

SLCO1B3 SLCO1B1

4.48e-053135222203093
Pubmed

The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.

CHD8 CHD6

4.48e-053135228533432
Pubmed

Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.

SLCO1B3 SLCO1B1

4.48e-053135220949553
Pubmed

SUMOylation of human septins is critical for septin filament bundling and cytokinesis.

SEPTIN3 SEPTIN7

4.48e-053135229051266
Pubmed

Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups.

SLCO1B3 SLCO1B1

4.48e-053135226409184
Pubmed

Synergistic interaction between genetics and disease on pravastatin disposition.

SLCO1B3 SLCO1B1

4.48e-053135224613363
Pubmed

Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms.

SLCO1B3 SLCO1B1

4.48e-053135225391605
Pubmed

Full-length cDNA cloning and genomic organization of the mouse liver-specific organic anion transporter-1 (lst-1).

SLCO1B3 SLCO1B1

4.48e-053135210833452
Pubmed

Interaction Between Sex and Organic Anion-Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib-N-Oxide and Regorafenib-Glucuronide in Mice.

SLCO1B3 SLCO1B1

4.48e-053135230955241
Pubmed

Influence of drug formulation on OATP1B-mediated transport of paclitaxel.

SLCO1B3 SLCO1B1

4.48e-053135224755470
Pubmed

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

SLCO1B3 SLCO1B1

4.48e-053135229337310
Pubmed

Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model.

SLCO1B3 SLCO1B1

4.48e-053135231967785
Pubmed

Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats.

SLCO1B3 SLCO1B1

4.48e-053135228013215
Pubmed

The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.

SLCO1B3 SLCO1B1

4.48e-053135219890249
Pubmed

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.

SLCO1B3 SLCO1B1

4.48e-053135220051929
Pubmed

Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1.

SLCO1B3 SLCO1B1

4.48e-053135229422623
Pubmed

Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel.

SLCO1B3 SLCO1B1

4.48e-053135224825069
Pubmed

Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.

LEPR THBS1

4.48e-053135224081879
Pubmed

Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure.

SLCO1B3 SLCO1B1

4.48e-053135222695893
Pubmed

Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.

SLCO1B3 SLCO1B1

4.48e-053135226383540
Pubmed

Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin.

SLCO1B3 SLCO1B1

4.48e-053135218413659
Pubmed

Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens.

SLCO1B3 SLCO1B1

4.48e-053135232587096
Pubmed

CD147 inhibits the nuclear factor of activated T-cells by impairing Vav1 and Rac1 downstream signaling.

BSG VAV1

4.48e-053135218160397
Pubmed

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer.

CD163 THBS1

4.48e-053135230254632
Pubmed

Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2.

SLCO1B3 SLCO1B1

4.48e-053135219400585
Pubmed

OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.

SLCO1B3 SLCO1B1

4.48e-053135230218633
Pubmed

Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide.

SLCO1B3 SLCO1B1

4.48e-053135210779507
Pubmed

Robo1 regulates semaphorin signaling to guide the migration of cortical interneurons through the ventral forebrain.

FLT4 ROBO1 PLXNA1

5.30e-0519135321508241
Pubmed

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

FLT4 LEPR CD163 ADGRL4 THBS1 FCGBP C4A

6.87e-05257135716335952
Pubmed

Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.

CAD OGT GLT1D1 HNRNPF GSN THBS1 GUCY2C PKD1 IFT122 CEP97

7.48e-055641351021565611
Pubmed

Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain.

SLCO1B3 SLCO1B1

8.93e-054135222294745
Pubmed

Adipocyte Xbp1s overexpression drives uridine production and reduces obesity.

CAD LEPR

8.93e-054135229551634
Pubmed

Stereocilin-deficient mice reveal the origin of cochlear waveform distortions.

STRC STRCP1

8.93e-054135218849963
Pubmed

Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

SLCO1B3 SLCO1B1

8.93e-054135220644253
Pubmed

Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cells.

SLCO1B3 SLCO1B1

8.93e-054135221849517
Pubmed

Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2.

SLCO1B3 SLCO1B1

8.93e-054135225280775
Pubmed

Genetic analysis of inferior nurturing ability in RR mice.

ZAN ZP3

8.93e-054135211869186
Pubmed

Expression of Netrin-1 and its two receptors DCC and UNC5H2 in the developing mouse lung.

SFTPB UNC5B

8.93e-054135212799072
Pubmed

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.

SLCO1B3 SLCO1B1

8.93e-054135219442037
Pubmed

Molecular Recognition at Septin Interfaces: The Switches Hold the Key.

SEPTIN3 SEPTIN7

8.93e-054135232910969
Pubmed

Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.

LEPR HNRNPF

8.93e-054135228424160
Pubmed

Protein O-GlcNAcylation Is Essential for the Maintenance of Renal Energy Homeostasis and Function via Lipolysis during Fasting and Diabetes.

OGT LEPR

8.93e-054135231043434
Pubmed

Spatiotemporal regulation of the GPCR activity of BAI3 by C1qL4 and Stabilin-2 controls myoblast fusion.

ADGRB3 GRIK4

8.93e-054135230367035
Pubmed

O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver.

OGT LEPR

8.93e-054135221471514
Pubmed

Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

SLCO1B3 SLCO1B1

8.93e-054135217906856
Pubmed

Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.

CD163 KMT2D

8.93e-054135228805986
Pubmed

Progesterone induced mesenchymal differentiation and rescued cystic dilation of renal tubules of Pkd1(-/-) mice.

WNT4 PKD1

8.93e-054135222835934
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MYBPH FLT4 UNC5B BSG PXDNL ROBO1

2.05e-04161956593
GeneFamilySolute carriers

SLC22A23 SLCO1B3 SLCO1B1 SLC47A2 SLC6A9 SLC39A12 SLC15A4 SLC22A14

1.12e-03395958752
ToppCellLPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB RAB11FIP1 ATP8A1 SHANK2 FMN1 UNC5CL

1.63e-061861357e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCellLPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB SLC22A23 ATP8A1 SHANK2 FMN1 UNC5CL

1.69e-061871357201ff693e4756ee3e44762885b3a303a77eb535b
ToppCellLPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT4 ANKRD37 UNC5B SLCO1B3 TDRD1 LEPR ADGRL4

1.82e-061891357e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTS4 CPB1 BDKRB1 GSN THBS1 NID1 PAPPA

2.39e-061971357ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTS4 CPB1 BDKRB1 GSN THBS1 NID1 PAPPA

2.39e-061971357b11a5d909942a4299cbc0b27332b1a3f66f3bccd
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

SFTPB APBB2 ATP8A1 SHANK2 FMN1 PRKCE AGAP1

2.47e-0619813571996373bdccc55aac347d349bd22f6aad6d0c668
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

SFTPB SLC22A23 ATP8A1 SHANK2 UNC5CL STRC PLXNA1

2.64e-0620013572dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellFetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ADAMTS4 SFTPB THBS1 ACSBG1 PAPPA LRRN4

7.34e-06153135665641cc82883716dba0fefb749a30174a63f4da5
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADAMTS4 BDKRB1 GSN PAPPA PLXNA1 CPEB1

9.14e-0615913567ed659163f45e0c4df4782997c0786900c8186c8
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor

CAPN9 IMPA2 SFTPB ATP8A1 SHANK2 AGAP1

1.05e-051631356e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell356C-Epithelial_cells-Epithelial-D_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells)

SLC22A23 HARBI1 GRIP1 C4A WDR90 LRRN4

1.17e-0516613562e4cb4056e6b0c43290a5588ff525f5f05b8beee
ToppCellfacs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM94 GRK4 CPA3 SLC6A9 PKD1 ABHD13

1.17e-05166135613027ae342994db4540e64eb910df1f42b160931
ToppCell356C-Epithelial_cells-Epithelial-D_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells)

SLC22A23 HARBI1 GRIP1 C4A WDR90 LRRN4

1.17e-051661356eb8d972326a734549675307e411fc795af66da70
ToppCellfacs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM94 GRK4 CPA3 SLC6A9 PKD1 ABHD13

1.17e-051661356b21e45bd43f26149b9cd6e45c19241c82d54fb2f
ToppCell368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SLC22A23 CPB1 WNT4 GRIP1 SHANK2 LRRN4

1.25e-051681356e870d2e69316406f45112ed0bf324b24f902a99e
ToppCell368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SLC22A23 CPB1 WNT4 GRIP1 SHANK2 LRRN4

1.25e-051681356403aba73a0f9ffb32252288d075fad8a588ca440
ToppCellP07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PPFIBP2 LGALS2 GRIP1 BSG SLC22A14 LRRN4

1.43e-0517213569a256db817c1af1802203cc88a55d608fb328c63
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB RAB11FIP1 ATP8A1 SHANK2 SPHKAP

1.53e-051741356d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CAPN9 CD248 SLCO1B3 RAB11FIP1 LEPR PLXNA1

1.68e-05177135630f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT4 BRIP1 ADAMTS4 ADGRL4 FAM111B NID1

1.68e-05177135673ba0f0b4b33f10e9f036d6d9befa48a1258e682
ToppCellAdult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor

SFTPB ATP13A5 FAM111B GRIP1 SHANK2 AGAP1

1.74e-05178135635a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCellLPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB RAB11FIP1 ATP8A1 SHANK2 FMN1

1.91e-0518113560513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PPFIBP2 LGALS2 GRIP1 BSG SLC22A14 LRRN4

1.91e-051811356330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PPFIBP2 LGALS2 GRIP1 BSG SLC22A14 LRRN4

1.91e-0518113563f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CD248 CPB1 LEPR GSN PXDNL NID1

1.97e-051821356d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CD248 PPFIBP2 DGKD SLC6A9 NID1 WDR17

2.03e-0518313568a799807fbf24456a9811e0c64068187940a2f71
ToppCellLPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB ATP8A1 SHANK2 FMN1 UNC5CL

2.03e-051831356e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANKK1 FLT4 CD248 WNT4 PAPPA LRRN4

2.03e-051831356ebe369dc80c4fbf8f4dbe947147f8c47507ffb60
ToppCellThalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Thalamus / BrainAtlas - Mouse McCarroll V32

FLT4 SLCO1B3 RAB11FIP1 ADGRL4 BSG

2.05e-0510913554e4a884b8979f4ff8b232c1581ea78884dda29ed
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SFTPB SLC22A23 ATP8A1 SHANK2 UNC5CL TNKS1BP1

2.09e-05184135642ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS4 CD248 PPFIBP2 SLC6A9 NID1 WDR17

2.09e-051841356689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCellcritical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

IMPA2 SFTPB TMEM171 THBS1 ADGRG2 ROBO1

2.09e-05184135658d36577eff814d46d72f031f3533d71549e3d6e
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB SLC22A23 ATP8A1 SHANK2 UNC5CL

2.09e-051841356cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SFTPB SLC22A23 ATP8A1 SHANK2 FMN1 UNC5CL

2.09e-051841356ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SFTPB SLC22A23 RAB11FIP1 GRIP1 SHANK2 UNC5CL

2.16e-0518513563bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCellfacs-Heart-LV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GLT1D1 WNT4 FCGBP ACSBG1 GUCY2C FMN1

2.16e-051851356a835f821a5e6568d648df831ec4c2d0048d67093
ToppCellfacs-Heart-LV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GLT1D1 WNT4 FCGBP ACSBG1 GUCY2C FMN1

2.16e-051851356386b08bcb304db543e3c5ff75f85e99bf0c592df
ToppCellpdx|World / Sample and Cell Type and Tumor Cluster (all cells)

BRIP1 SLC22A23 APBB2 DGKD ROBO1 AGAP1

2.22e-051861356de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SFTPB SLC22A23 RAB11FIP1 ATP8A1 SHANK2 UNC5CL

2.22e-0518613564e94158db52df41d71e67b02b9895a358eebee0f
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SFTPB SLC22A23 RAB11FIP1 GRIP1 ATP8A1 SHANK2

2.22e-0518613563aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellpdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

BRIP1 SLC22A23 APBB2 DGKD ROBO1 AGAP1

2.22e-0518613560b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD248 XPNPEP2 SLC22A14 NID1 PAPPA LRRN4

2.29e-0518713564e553721fa5598cb211f44e3226280b7e6885484
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SFTPB SLC22A23 ATP8A1 SHANK2 UNC5CL TNKS1BP1

2.29e-05187135658d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD248 XPNPEP2 SLC22A14 NID1 PAPPA LRRN4

2.29e-051871356d36e7fc6125e7a4310499365022d38f34b757a73
ToppCelldroplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD248 XPNPEP2 SLC22A14 NID1 PAPPA LRRN4

2.29e-051871356827eae63fabf6892a82ce7779b5f395958d3d628
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BRIP1 NCAPH CD163 FAM111B FCGBP VAV1

2.29e-05187135673931a5ea73799095daff100b5f18853c57c74dc
ToppCelldroplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLT4 SLC22A23 APBB2 XPNPEP2 ADGRL4 PRKCE

2.36e-051881356db0652f000d459493321b53239326706eace598c
ToppCellLPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB ATP8A1 SHANK2 FMN1 UNC5CL

2.36e-0518813566164d467b612767ceba15de34176bcc8e8c36ab8
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IMPA2 SFTPB SLC22A23 RAB11FIP1 ATP8A1 SHANK2

2.36e-05188135643a0508d2524a5b310e89e9422843dcaab999bc3
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SFTPB SLC22A23 ATP8A1 SHANK2 FMN1 SPHKAP

2.36e-0518813564bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS4 XPNPEP2 BDKRB1 GSN THBS1 PAPPA

2.58e-051911356f5ce33af56178333730be308253943c54a0724cf
ToppCell5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTS4 CPB1 GSN THBS1 NID1 PAPPA

2.66e-0519213569479e9859140ba98abfe88414de0b28fc2bf43b7
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS4 XPNPEP2 BDKRB1 GSN THBS1 PAPPA

2.66e-051921356a8b7c539dc3037071bf068f372e4215563e11de4
ToppCell5'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTS4 CPB1 GSN THBS1 NID1 PAPPA

2.66e-051921356d7faa993f68e530ad55185505384ae155d36c222
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS4 XPNPEP2 BDKRB1 GSN THBS1 PAPPA

2.66e-0519213562143e1fad2e88b90d668e12af37b2092d379090f
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS4 XPNPEP2 BDKRB1 GSN THBS1 PAPPA

2.66e-051921356904c003c4f73b1dfc8243cee02aad2676c515e50
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

APBB2 SLCO1B3 GRIK4 LEPR ADGRL4 PRKCE

2.74e-0519313566e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCelldistal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ADGRB3 CD163 LGALS2 SLC39A12 FCGBP FMN1

2.74e-05193135648ce11778252ae2ef902b30816061b59a3c81695
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

ADGRB3 CHD9 GSN ROBO1 NID1 PAPPA

2.74e-051931356dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCellRV-02._Fibroblast_II|RV / Chamber and Cluster_Paper

ADGRB3 CHD9 GSN ROBO1 NID1 PAPPA

2.82e-05194135611c79a8c56ece42713b04b321982e41e239f07a5
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ADAMTS4 UNC5B GSN ATP8A1 ARHGAP21 AGAP1

2.82e-051941356cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCellLV-02._Fibroblast_II|LV / Chamber and Cluster_Paper

ADGRB3 CHD9 GSN ROBO1 NID1 PAPPA

2.82e-051941356014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCellRA|World / Chamber and Cluster_Paper

ADAMTS4 GSN GRIP1 THBS1 PXDNL PAPPA

2.82e-05194135608f0afbb68a63150fbe107a5337299081c3f69e4
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

APBB2 SLCO1B3 GRIK4 LEPR ADGRL4 PRKCE

2.82e-0519413560b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellLA-02._Fibroblast_II|LA / Chamber and Cluster_Paper

ADGRB3 CHD9 GSN ROBO1 NID1 AGAP1

2.82e-051941356234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCellHippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Hippocampus / BrainAtlas - Mouse McCarroll V32

ANKK1 ZP3 BDKRB1 UNC5CL GTSF1L

2.89e-05117135591936a3ffbfa29024ced9d01df962b4ccfaf8966
ToppCellHippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

ANKK1 ZP3 BDKRB1 UNC5CL GTSF1L

2.89e-051171355e33ec9044541d2ef53f6633891238559b01b7957
ToppCellHippocampus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Hippocampus / BrainAtlas - Mouse McCarroll V32

ANKK1 ZP3 BDKRB1 UNC5CL GTSF1L

2.89e-051171355454efceabe739cdf293f81c8a938811f12321a47
ToppCellHippocampus-Macroglia-CSF_related-EPENDYMAL|Hippocampus / BrainAtlas - Mouse McCarroll V32

ANKK1 ZP3 BDKRB1 UNC5CL GTSF1L

2.89e-051171355409b3ab16786bced8c9bc9c0e89b0078402f365a
ToppCellIPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class

DCDC1 SFTPB SLC22A23 SHANK2 CFAP46 AGAP1

2.90e-051951356fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

ADGRB3 CHD9 GSN ROBO1 NID1 AGAP1

2.90e-051951356a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCellRV-02._Fibroblast_II|World / Chamber and Cluster_Paper

ADGRB3 CHD9 GSN ROBO1 NID1 PAPPA

2.90e-051951356ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCellIPF-Multiplet|IPF / Disease state, Lineage and Cell class

DCDC1 SFTPB SLC22A23 SHANK2 CFAP46 AGAP1

2.90e-051951356eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCellRA-02._Fibroblast_II|RA / Chamber and Cluster_Paper

ADGRB3 CHD9 GSN ROBO1 NID1 PAPPA

2.90e-0519513566a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ADAMTS4 CPB1 BDKRB1 GSN THBS1 NID1

2.90e-051951356fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCellfacs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC22A23 APBB2 XPNPEP2 ATP8A1 PRKCE PLXNA1

2.90e-051951356cad21edd90bf3e2fefdf5773a59cb1a664a69ddd
ToppCell(5)_Fibroblast-J_(Lipofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

ADAMTS4 CPB1 WNT4 BDKRB1 LGALS2 GUCY2C

2.98e-051961356afa29399decd17fda7d63add5039ff778627ccc2
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SFTPB SLC22A23 ATP8A1 SHANK2 SLC22A14 UNC5CL

3.07e-0519713563d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

ADGRB3 GRIK4 THBS1 ROBO1 NID1 PAPPA

3.16e-051981356df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CD248 CPB1 GSN ADGRG2 PXDNL NID1

3.25e-0519913561fd7bbb8727607e6507848602a19bc86882ef2d5
ToppCellTracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CAPN9 SLC22A23 DGKD EDEM3 SHANK2 FMN1

3.34e-052001356c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CD248 PPFIBP2 DGKD SLC6A9 NID1 SEPTIN7

3.34e-0520013564e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CD248 XPNPEP2 LEPR GSN NID1 PAPPA

3.34e-05200135644317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

CD248 PPFIBP2 DGKD SLC6A9 NID1 SEPTIN7

3.34e-052001356786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADGRB3 GRIK4 THBS1 ROBO1 NID1 PAPPA

3.34e-052001356cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellLPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type

CD248 PPFIBP2 SLC6A9 ROBO1 NID1 WDR17

3.34e-05200135669edc375d85689300d1dbc1217fedc40063ecdcb
ToppCellcellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CD248 XPNPEP2 LEPR GSN NID1 PAPPA

3.34e-0520013561c10597edd532bf172ca09870a937d35e2585081
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CD248 XPNPEP2 LEPR GSN NID1 PAPPA

3.34e-052001356440dda48b09c6a8581b7ca634b0d67f1ecacf65e
ToppCell(54)_pDC|World / shred on Cell_type and subtype

ZAN GLT1D1 XPNPEP2 SLC15A4 MED12L MED26

3.63e-052031356b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

RPH3AL XPNPEP2 ADGRG2 PXDNL KCNJ9

3.67e-05123135512b87d06e62f142e18424aae5c87454e78e713f0
ToppCellLPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

BRIP1 ADAMTS4 CD248 PKD1 WDR17

3.97e-0512513552938a1d62afe1e0a3abba5eb92f07b886cc0accd
ToppCellTCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9

OGT CHD9 MIPOL1 KMT2D WDR17

5.73e-051351355ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCellStriatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Striatum / BrainAtlas - Mouse McCarroll V32

FLT4 SLCO1B3 RAB11FIP1 ADGRL4 BSG

6.14e-051371355306b11b3b9e5fd562d845fb5eaa4ac982864efce
ToppCellStriatum-Endothelial-ENDOTHELIAL_STALK|Striatum / BrainAtlas - Mouse McCarroll V32

FLT4 SLCO1B3 RAB11FIP1 ADGRL4 BSG

6.14e-051371355d37f425b13bc046baa1f8619b98a16b936f88ff6
ToppCellfacs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT4 LEPR ADGRL4 SPHKAP NID1

1.10e-0415513558fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCellLPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CD248 PPFIBP2 SLC6A9 MED12L NID1

1.17e-041571355bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor

IMPA2 SFTPB FCGBP ATP8A1 AGAP1

1.17e-04157135531d1bd9138c60e8485664ec4144f987226e3eef9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ZP3 FAM111B NID1 IFT122 WDR17

1.20e-041581355d72d6527dc50207ddbada262460d3c4bac249a19
ToppCellfacs-Large_Intestine-Distal-18m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CAPN9 UNC5B CD163 GSN FCGBP

1.24e-041591355c9e093d7c1dca83f6546adaf3d874929e2cea612
ToppCellPosterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

FLT4 RAB11FIP1 ADGRL4 BSG

1.24e-04841354f7ce09c6fb2795b7aecabce00cb9830b3c1a7d0e
DiseaseCHARGE syndrome (implicated_via_orthology)

CHD9 CHD8 CHD6

2.95e-0671313DOID:0050834 (implicated_via_orthology)
Diseaseautosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)

STRC STRCP1

1.96e-0521312DOID:0110471 (implicated_via_orthology)
DiseaseHYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC

SLCO1B3 SLCO1B1

1.96e-0521312C4016905
DiseaseRotor Syndrome

SLCO1B3 SLCO1B1

1.96e-0521312C0220991
DiseaseRotor syndrome

SLCO1B3 SLCO1B1

1.96e-0521312cv:C0220991
DiseaseHYPERBILIRUBINEMIA, ROTOR TYPE

SLCO1B3 SLCO1B1

1.96e-0521312237450
Diseasebilirubin metabolic disorder (implicated_via_orthology)

SLCO1B3 SLCO1B1

1.94e-0451312DOID:2741 (implicated_via_orthology)
Diseasecongenital heart disease (implicated_via_orthology)

CHD9 CHD8 KMT2D CHD6

2.57e-04691314DOID:1682 (implicated_via_orthology)
Diseasebilirubin metabolic disorder (is_implicated_in)

SLCO1B3 SLCO1B1

2.90e-0461312DOID:2741 (is_implicated_in)
Disease5alpha-pregnan-diol disulfate measurement

ZNF680 SLCO1B1

2.90e-0461312EFO_0800286
Diseasedeoxycholic acid glucuronide measurement

SLCO1B3 SLCO1B1

5.38e-0481312EFO_0800575
Diseasebreast ductal carcinoma (is_marker_for)

SLCO1B3 BSG

5.38e-0481312DOID:3007 (is_marker_for)
Diseaseurate measurement

DCDC1 CD248 SLCO1B1 MIPOL1 TMEM171 THBS1 SHANK2 FMN1 UNC5CL NID1 GJA10 KLB

6.59e-0489513112EFO_0004531
Diseasehexadecenedioate (C16:1-DC) measurement

SLCO1B3 SLCO1B1

6.90e-0491312EFO_0800562
DiseaseX-21467 measurement

SLCO1B3 SLCO1B1

6.90e-0491312EFO_0020007
Diseaseblood urea nitrogen measurement

DCDC1 CHD9 HNRNPF MIPOL1 TMEM171 ROBO1 WDR90 KLB

9.56e-044521318EFO_0004741
Diseasepregnenediol disulfate (C21H34O8S2) measurement

ZNF680 SLCO1B1

1.05e-03111312EFO_0800279
Diseasediabetic retinopathy (biomarker_via_orthology)

BDKRB1 THBS1 ROBO1

1.06e-03451313DOID:8947 (biomarker_via_orthology)
DiseaseWeight Gain

APBB2 LEPR GSN NID1

1.13e-031021314C0043094
Diseaseintracranial aneurysm (is_implicated_in)

KMT2D PKD1

1.25e-03121312DOID:10941 (is_implicated_in)
DiseaseAlzheimer disease, dementia

CFAP46 OCSTAMP

1.25e-03121312MONDO_0001627, MONDO_0004975
Diseaseresponse to atorvastatin, myopathy

ZNF676 GARRE1

1.48e-03131312EFO_0004145, EFO_0010124
Diseaseglycochenodeoxycholate glucuronide (1) measurement

SLCO1B3 SLCO1B1

1.48e-03131312EFO_0800474
Diseasecolon carcinoma (is_marker_for)

SLCO1B3 KMT2D

1.48e-03131312DOID:1520 (is_marker_for)
Diseaserenal sinus adipose tissue measurement

GLT1D1 SLC15A4

1.48e-03131312EFO_0004864
Diseaseuric acid measurement

FLT4 DCDC1 XPNPEP2 SLCO1B1 MIPOL1 TMEM171 FMN1 UNC5CL KLB

1.65e-036101319EFO_0004761
Disease3-hydroxyphenylacetic acid measurement

ADGRG2 PAPPA

1.72e-03141312EFO_0010448
Diseasepulmonary fibrosis (is_implicated_in)

SFTPB BDKRB1

2.25e-03161312DOID:3770 (is_implicated_in)
DiseaseAntibody Deficiency Syndrome

LEPR C4A

2.55e-03171312C0003257
Diseasehypertension (implicated_via_orthology)

MYBPH BDKRB1 LEPR PRKCE

2.59e-031281314DOID:10763 (implicated_via_orthology)
Diseasealcohol use disorder measurement

ANKK1 UNC5B GRK4 TMX2 KLB

2.72e-032141315EFO_0009458
Diseaseobesity (implicated_via_orthology)

CAPN9 ADAMTS4 LEPR GUCY2C MED12L

2.78e-032151315DOID:9970 (implicated_via_orthology)
Diseaseglomerulonephritis (is_marker_for)

BDKRB1 CD163

3.18e-03191312DOID:2921 (is_marker_for)
Diseasemaximal midexpiratory flow rate

BRIP1 MED12L

3.53e-03201312EFO_0004313
Diseasemean corpuscular hemoglobin concentration

BRIP1 GMPR2 SLCO1B1 LEPR ADGRL4 MIPOL1 SLC6A9 ACSBG1 PRKCE ARHGAP21 CAPN15 AGAP1

3.83e-03110513112EFO_0004528
Diseaserenal system measurement, blood urea nitrogen measurement

DCDC1 TMEM171

4.26e-03221312EFO_0004741, EFO_0004742

Protein segments in the cluster

PeptideGeneStartEntry
VANVIPAEGNWSSDC

TDRD1

381

Q9BXT4
AIFPDGTHNDTWQCQ

ABHD13

291

Q7L211
TENNFIWSFIGPACL

ADGRL4

566

Q9HBW9
QNATACDNAPEAWDL

BDKRB1

21

P46663
LDLWGTVPTADNCFQ

ATP13A5

496

Q4VNC0
ADTCIIFDSDWNPQN

CHD8

1221

Q9HCK8
DCETQNPNWASLNLG

AGAP1

626

Q9UPQ3
WCEPNAGNVSEAVQA

APBB2

686

Q92870
FWNAISQCENSADEP

ANAPC2

91

Q9UJX6
NFTNCTWTLENPDPT

ADGRB3

51

O60242
WCSQQDTQSPFQTGT

C2orf48

91

Q96LS8
LQCGADPNAAEQSGW

ANKK1

646

Q8NFD2
EWLPFGSVAAVQCQA

CD248

191

Q9HCU0
RNCPSFAVGTWEQSQ

GJA10

376

Q969M2
NGSPDDFCWINNNAV

ADGRG2

771

Q8IZP9
FPSQAQWEQALGSCS

CFAP46

2461

Q8IYW2
DVAANWSQNRTPCAG

AMN

31

Q9BXJ7
NSDFCAPLTSFDWNE

DCAF7

116

P61962
GCSPDEWQNSQFGDE

ATP8A1

441

Q9Y2Q0
NGQTAEDLAWSCGFP

ANKRD37

96

Q7Z713
DCFQSAGDWQGELPV

FMN1

131

Q68DA7
QPGWLSFSSQVSQNC

GUCY2C

16

P25092
AWTPCVNNLNGFVAA

KCNJ9

96

Q92806
WQEARVQGCFPSSAS

CAPN15

796

O75808
NWEVCEGFPINFNCT

DCDC1

626

M0R2J8
QEPNANSVAWNTQCE

IFT122

551

Q9HBG6
CDGNADDIWTASQNP

MED12L

1211

Q86YW9
CENTEWPGQRSTNFQ

MIPOL1

51

Q8TD10
PDIWNVDGANCQHVF

GTSF1L

101

Q9H1H1
NSPAWHDEFVTDVCN

PRKCE

61

Q02156
DSNFDWTCPNTQILF

EDEM3

521

Q9BZQ6
TGIQQTFPCSNWLDE

LOXHD1

386

Q8IVV2
CRENSGNLWAFESPV

C9orf131

416

Q5VYM1
TNWPGSLQDCAVLQQ

HARBI1

191

Q96MB7
AWNVPDLSAGVNCSF

PLXNA1

586

Q9UIW2
PNGLTFDAFSSQLCW

NID1

1111

P14543
GFNCAEAINFATPRW

KDM4D

286

Q6B0I6
CSWAQGLNFQKPETF

LEPR

881

P48357
SLVQWQEFAGQNPDC

GMPR2

81

Q9P2T1
VCNSLDGSNWGQEQR

LGALS2

56

P05162
PQGFLDQWASNASVS

PAPPA

1016

Q13219
LAAGPWEECFQAAVQ

IMPA2

11

O14732
QASQWPGVNGCQDTQ

MED26

556

O95402
ANAPFAQWSTERVCA

PPFIBP2

551

Q8ND30
FWCLNPAVAFSDING

BRIP1

591

Q9BX63
WQQECQLASGPADTE

ACP2

366

P11117
ACAELQQPALAGADW

PCTP

16

Q9UKL6
DGTCNNLQQPTWGAA

PXDNL

731

A1KZ92
TNSWENFRQGIDFCP

GALNS

406

P34059
SFCAWQRGLNTPEDS

ADAMTS4

291

O75173
DTCIIFDSDWNPQND

CHD9

1271

Q3L8U1
CGNQSPSWAAEDIIN

HECTD1

2491

Q9ULT8
CDALGNWNPQNAVAL

GPCPD1

26

Q9NPB8
ASWNSIPNTNDPCAD

CPA3

256

P15088
SQGIATTPNAAFNWN

GLT1D1

136

Q96MS3
ADTCIIFDSDWNPQN

CHD6

871

Q8TD26
CGNFNGNWSDDFVLP

FCGBP

4986

Q9Y6R7
CDQNADWFIASDVAP

CEP97

676

Q8IW35
QSPVWAATNDCSAAA

GARRE1

1016

O15063
QGPNDTCSQLWDGAR

BSG

61

P35613
GIQWGAQVCFAEPDA

ACSBG1

341

Q96GR2
LGWGSACDDDTQLPQ

DGKD

416

Q16760
DVQGQFPCDFSWGVT

KLB

516

Q86Z14
SSFQPACSDFVGWQS

KRTAP25-1

81

Q3LHN0
WDNQEAPALSTCSNA

CPEB1

16

Q9BZB8
TEVPVSWESFNNGDC

GSN

201

P06396
WDNNGNTGNATCFVF

FAM111B

466

Q6SJ93
NQSWQENCDHVPFTG

GRIK4

286

Q16099
QSLPGDWSEQNSAFF

GRIP1

1096

Q9Y3R0
ARFATGCVSIPWQNE

GRK4

501

P32298
QEGTSVLPFWNCDFL

FDXACB1

271

Q9BRP7
FQGRWGTVCDDNFNI

CD163

176

Q86VB7
GCRNFLDTFWTNPQI

CAPN9

366

O14815
NCGNSFQLVSEGASW

FAM53C

36

Q9NYF3
QFGLNDTDTCQDGWI

SLC22A14

146

Q9Y267
FLNGAPFCWEGAQAS

SLC15A4

61

Q8N697
DGPVSWDQTCFSARQ

SLC39A12

301

Q504Y0
IGTDPNRNFDAGWCE

CPB1

246

P15086
WELSSFEEPGNQCTE

MFSD14B

491

Q5SR56
WLLSQQQADGSFQDP

C4A

1106

P0C0L4
QNCNLSSFPPWTLDS

LRRN4

286

Q8WUT4
APQGEAFSLESCQNW

PKD1

481

P98161
SWVSSFPFCGLNEIN

OR10A6

161

Q8NH74
TQPNFAVAWSNLGCV

OGT

186

O15294
WLEGNPLCSTFSDQS

NXF2

326

Q9GZY0
FGSGNDQWVCPNDRQ

RPH3AL

6

Q9UNE2
RGLPWSCSVEDVQNF

HNRNPF

16

P52597
LEDPAHFEVWCQNTG

PARS2

441

Q7L3T8
QELNPAWSVAGNASD

RAB11FIP1

836

Q6WKZ4
SGNLQADFEVSQCPW

SPHKAP

136

Q2M3C7
ACAQGPEFWCQSLEQ

SFTPB

31

P07988
SSQCLQDWGPFFSLA

SLC47A2

281

Q86VL8
SDSFLLDQPNFWCRG

SLC22A23

116

A1A5C7
IEPAESLGQAVNCWS

PRDM7

371

Q9NQW5
CNAALQWTPPQDTGN

MYBPH

281

Q13203
QAAWDAFSQPVPASC

OCSTAMP

31

Q9BR26
PAAVFGCDWSQNNKD

WDR17

521

Q8IZU2
DESQWEPVCGNNGIT

SLCO1B1

466

Q9Y6L6
QGWLQACHDQFPDEF

STRC

406

Q7RTU9
NSDNNLNASAPDWAV

SHANK2

421

Q9UPX8
QVQCSDSQASGDAFW

ANHX

351

E9PGG2
CPSLAGFQFTQWDSE

NCAPH

316

Q15003
DETGLWQCPFCQQDN

SUPT6H

1191

Q7KZ85
EFFANWSNDCQSFAP

TMX2

161

Q9Y320
DGWPNENLVCVANAT

THBS1

696

P07996
AFNPWDAGELTCVGQ

WDR90

1256

Q96KV7
CSHFSQEFWPEQGIE

ZNF676

46

Q8N7Q3
WNNCFTEEGPSSVRF

NHLRC3

251

Q5JS37
DQQNPSCIQFDDSNW

TMEM94

561

Q12767
TPGFGDQINNENCWE

SEPTIN3

126

Q9UH03
GFGDAVDNSNCWQPV

SEPTIN7

116

Q16181
NTSTNEIGWFPCNRV

VAV1

641

P15498
PEFISVCNNATWAIG

TNPO2

716

O14787
DESQWEPVCGNNGIT

SLCO1B3

466

Q9NPD5
AFSPGQQDWSRDFCI

TNKS1BP1

1101

Q9C0C2
CETTWGDQDFLSNPF

FLT4

206

P35916
GACWTLNGQEEPVSQ

UNC5CL

41

Q8IV45
IWNAGPVCQSTAEAA

YJEFN3

61

A6XGL0
AGWQLSAEADACPSV

KRT10-AS1

161

Q8N816
NNPWNTHDCAGVLDA

SLC6A9

221

P48067
VEFQVQGSWAPLCAT

SCART1

341

Q4G0T1
LADTWPNTGNNHNDC

ROBO1

976

Q9Y6N7
GFCFLTNQWAVTDPE

nan

121

A8MWL6
CGSNWAQEPLNETDT

TMEM171

136

Q8WVE6
ICNSLDAPNSRGNDW

UNC5B

866

Q8IZJ1
ADWAPLFTNANDGSN

CAD

306

P27708
CFRGDWEGNTQFQTL

ZNF790

116

Q6PG37
SPQGFQWSGCSDNIA

WNT4

146

P56705
QGWLQACHDQFPDEF

STRCP1

406

A6NGW2
QQDPFCFSGKAEWIQ

ZNF875

161

P10072
CVHEWPVGFQSNNIA

XPNPEP2

531

O43895
DPQGVESFAVWCAQA

TRIM64C

321

A6NLI5
NDQETGSDTTCWLPN

ARHGAP21

761

Q5T5U3
SNSWFPVEGSADICQ

ZP3

306

P21754
TAGRQEVDNTFWNGC

PJA2

401

O43164
ECGNVFNWPATLANH

ZNF680

466

Q8NEM1
EDNAHPFCDWVQTSG

ZAN

376

Q9Y493
CGAGSAELNPNSEWF

KMT2D

326

O14686